J'ai eu la chance d'être parmi les premiers à bénéficier de cette formation. Entre la théorie présentée par Sylvie, Daniela et Olivier, ainsi que la pratique au sein du groupe de l'UMD, cette formation est vraiment complète et essentielle pour tout aspirant thérapeute en addiction. Elle permet d'obtenir la fondation nécessaire pour poursuivre d'autres formations qu'elles soient théoriques ou pratiques. Super expérience.

Chambre très classe et propre, individuel avec l'assurance de base c'est excellent après avoir été opérée et on a des douleurs c'est bien d'être seul .Une équipe professionnelle a l'écoute est très attentionnée et sympathique. Spécialement Tamara et David je les remercie pour leurs professionnalismes. Repas bon et de calite

Hirslanden is committed to high-quality, responsible and efficiently integrated healthcare that focuses on the needs of the individual. Working together with private and public cooperation partners, the Hirslanden Group prioritises ongoing development of the Continuum of Care concept. From birth to old age, from prevention to healing, Hirslanden is always there, both on a physical and digital level. Hirslanden differentiates itself from the rest of the market as a service provider with first-class medical and service quality, which is guaranteed by highly qualified independent specialists with years of experience who offer excellent care and services. Interdisciplinary medical centres of expertise, specialised institutes and competent cooperation partners enable optimal, personalised diagnosis and treatment, regardless of case complexity, in both inpatient and outpatient contexts. The Hirslanden Group operates 17 hospitals in 10 cantons, many of which have an emergency department. It also operates 5 outpatient surgery centres, 18 radiology and 6 radiotherapy institutes. The Group has 2,515 partner doctors and 11,025 employees, 551 of whom are permanently employed doctors. Hirslanden is the largest medical network in Switzerland. In the 2021/22 financial year, the Group generated turnover of CHF 1,885 million. As at 31 March 2022, the Group had treated 109,624 patients for a total of 472,301 inpatient days. The patient mix consists of 51.3% patients with basic insurance, 28.2% with semi-private insurance and 20.5% with private insurance. The Hirslanden Group was formed in 1990 through the merger of several hospitals. Since 2007, it has been part of the international hospital group Mediclinic International plc, which is listed on the London Stock Exchange.